Skeletal muscle and nerve channelopathies
| Ion channel | Disorder | Inheritance | Gene | Chromosome | |||
| Voltage gated | |||||||
| Potassium | Familial generalised myokymia | Dominant | Kv1.1 | 12p | |||
| Sodium | HyperPP | Dominant | SCNA4 | 17q | |||
| Paramyotonia congenita | Dominant | ||||||
| PAM | Dominant | ||||||
| Calcium | HypoPP | Dominant | CACLN1A3 | 1q | |||
| Malignant hyperthermia | Dominant | ||||||
| Calcium | Central core disease | Dominant | RYR1 | 19q | |||
| Malignant hyperthermia | Dominant | ||||||
| Chloride | Myotonia congenita | CLCN1 | 7q | ||||
| Thomsen's disease | Dominant | ||||||
| Becker's myotonia | Recessive | ||||||
| Potassium (cochlea) | Jervell and Lange–Nielsen syndrome | Recessive | KCNQ1 | 11p | |||
| (Long QT and deafness) | Recessive | KCNE1 | 21q | ||||
| Autosomal dominant deafness type 2 | Dominant | KCNQ4 | 1p | ||||
| Calcium (retina) | Stationary night blindness | X linked | CACNA1F | Xp | |||
| Ligand gated | |||||||
| Nicotinic acetylcholine receptor | Congenital myasthenia | Dominant and recessive | CHRNA | 2q | |||
| CHRNG | |||||||
| CHRND | |||||||
| CHRNB | 17p | ||||||
| CHRNE | |||||||
HyperPP, hyperkalaemic periodic paralysis; PAM, potassium aggravated myotonia; HypoPP, hypokalaemic periodic paralysis.